Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details) - $ / shares		3 Months Ended	12 Months Ended
	Nov. 10, 2011	Mar. 31, 2017	Dec. 31, 2016
Expected life (in months)	60 months
Expected volatility	104.50%
Risk-free interest rate	0.875%
Exercise price	$ 0.81
Fair value per share	$ 0.54
Warrants Revalued at December 31, 2016 [Member]
Expected life (in months)			5 months
Expected volatility			83.50%
Risk-free interest rate			0.62%
Exercise price			$ 0.25
Fair value per share			$ 0.02
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member]
Risk-free interest rate			1.93%
Exercise price			$ 0.40
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)			43 months
Expected volatility			110.00%
Fair value per share			$ 0.12
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)			51 months
Expected volatility			116.00%
Fair value per share			$ 0.14
Warrants Revalued at March 31, 2017 [Member]
Expected life (in months)		1 month 6 days
Expected volatility		98.30%
Risk-free interest rate		0.74%
Exercise price		$ 0.25
Fair value per share		$ 0.08
Warrants Revalued at March 31, 2017 [Member] \| Warrants Issued with Convertible Debt [Member]
Risk-free interest rate		1.50%
Exercise price		$ 0.40
Warrants Revalued at March 31, 2017 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)		40 months
Expected volatility		106.00%
Fair value per share		$ 0.21
Warrants Revalued at March 31, 2017 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)		48 months
Expected volatility		110.00%
Fair value per share		$ 0.23
Issuance Fair Value [Member] \| Minimum [Member]
Expected life (in months)		6 months
Expected volatility		104.20%
Risk-free interest rate		0.05%
Exercise price		$ 0.10
Fair value per share		$ 0.09
Issuance Fair Value [Member] \| Maximum [Member]
Expected life (in months)		24 months
Expected volatility		153.80%
Risk-free interest rate		0.99%
Exercise price		$ 0.35
Fair value per share		$ 0.28
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member]
Expected life (in months)		60 months
Exercise price		$ 0.40
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected volatility		118.30%
Risk-free interest rate		1.48%
Fair value per share		$ 0.19
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected volatility		120.10%
Risk-free interest rate		1.69%
Fair value per share		$ 0.21
At Settlement Fair Value [Member] \| Minimum [Member]
Expected life (in months)		0 months
Expected volatility		86.90%
Risk-free interest rate		0.01%
Exercise price		$ 0.10
Fair value per share		$ 0.07
At Settlement Fair Value [Member] \| Maximum [Member]
Expected life (in months)		18 months
Expected volatility		142.20%
Risk-free interest rate		0.72%
Exercise price		$ 0.25
Fair value per share		0.26
Conversion Options Revalued at December 31, 2016 [Member]
Exercise price			$ 0.28
Conversion Options Revalued at December 31, 2016 [Member] \| Minimum [Member]
Expected life (in months)			6 months
Expected volatility			84.40%
Risk-free interest rate			0.62%
Fair value per share			$ 0.03
Conversion Options Revalued at December 31, 2016 [Member] \| Maximum [Member]
Expected life (in months)			15 months
Expected volatility			94.80%
Risk-free interest rate			0.85%
Fair value per share			$ 0.06
Conversion Options Revalued at March 31, 2017 [Member]
Exercise price		$ 0.28
Conversion Options Revalued at March 31, 2017 [Member] \| Minimum [Member]
Expected life (in months)		3 months
Expected volatility		90.20%
Risk-free interest rate		0.91%
Fair value per share		$ 0.10
Conversion Options Revalued at March 31, 2017 [Member] \| Maximum [Member]
Expected life (in months)		12 months
Expected volatility		109.30%
Risk-free interest rate		1.03%
Fair value per share		$ 0.13